These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12065847)

  • 21. Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma.
    Abdulkadir SA; Carbone JM; Naughton CK; Humphrey PA; Catalona WJ; Milbrandt J
    Hum Pathol; 2001 Sep; 32(9):935-9. PubMed ID: 11567222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.
    Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR
    Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective contribution of Egr1 (zif/268) to persistent inflammatory pain.
    Ko SW; Vadakkan KI; Ao H; Gallitano-Mendel A; Wei F; Milbrandt J; Zhuo M
    J Pain; 2005 Jan; 6(1):12-20. PubMed ID: 15629414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation.
    Erickson-Miller CL; Pelus LM; Lord KA
    Stem Cells; 2000; 18(5):366-73. PubMed ID: 11007921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3.
    Lin J; Tang H; Jin X; Jia G; Hsieh JT
    Oncogene; 2002 May; 21(19):3082-8. PubMed ID: 12082540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homozygous deletion of early growth response 1 gene and critical limb ischemia after vascular ligation in mice: evidence for a central role in vascular homeostasis.
    Schalch P; Patejunas G; Retuerto M; Sarateanu S; Milbrandt J; Thakker G; Kim D; Carbray J; Crystal RG; Rosengart TK
    J Thorac Cardiovasc Surg; 2004 Oct; 128(4):595-601. PubMed ID: 15457161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of early growth response genes in human prostate cancer.
    Eid MA; Kumar MV; Iczkowski KA; Bostwick DG; Tindall DJ
    Cancer Res; 1998 Jun; 58(11):2461-8. PubMed ID: 9622090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilization of bone marrow-derived endothelial cell precursors in spontaneous prostate tumors varies with tumor grade.
    Li H; Gerald WL; Benezra R
    Cancer Res; 2004 Sep; 64(17):6137-43. PubMed ID: 15342397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early growth response protein 1 upregulation and nuclear translocation by 2'-benzoyloxycinnamaldehyde induces prostate cancer cell death.
    Kang HS; Ock J; Lee HJ; Lee YJ; Kwon BM; Hong SH
    Cancer Lett; 2013 Feb; 329(2):217-27. PubMed ID: 23178451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E2F1 Induces tumor cell survival via nuclear factor-kappaB-dependent induction of EGR1 transcription in prostate cancer cells.
    Zheng C; Ren Z; Wang H; Zhang W; Kalvakolanu DV; Tian Z; Xiao W
    Cancer Res; 2009 Mar; 69(6):2324-31. PubMed ID: 19276347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
    Tyagi A; Agarwal R; Agarwal C
    Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Id proteins and angiogenesis.
    Benezra R; Rafii S; Lyden D
    Oncogene; 2001 Dec; 20(58):8334-41. PubMed ID: 11840326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
    Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
    Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
    Tørring N; Jørgensen PE; Sørensen BS; Nexø E
    Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wild-type egr1/Krox24 promotes and dominant-negative mutants inhibit, pluripotent differentiation of p19 embryonal carcinoma cells.
    Lanoix J; Mullick A; He Y; Bravo R; Skup D
    Oncogene; 1998 Nov; 17(19):2495-504. PubMed ID: 9824160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early growth response protein 1 binds to the luteinizing hormone-beta promoter and mediates gonadotropin-releasing hormone-stimulated gene expression.
    Wolfe MW; Call GB
    Mol Endocrinol; 1999 May; 13(5):752-63. PubMed ID: 10319325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hedgehog pathway activity in the LADY prostate tumor model.
    Gipp J; Gu G; Crylen C; Kasper S; Bushman W
    Mol Cancer; 2007 Mar; 6():19. PubMed ID: 17343742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
    Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
    Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A network of p73, p53 and Egr1 is required for efficient apoptosis in tumor cells.
    Yu J; Baron V; Mercola D; Mustelin T; Adamson ED
    Cell Death Differ; 2007 Mar; 14(3):436-46. PubMed ID: 16990849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced EGR1 activity promotes the growth of prostate cancer cells in an androgen-depleted environment.
    Yang SZ; Eltoum IA; Abdulkadir SA
    J Cell Biochem; 2006 Apr; 97(6):1292-9. PubMed ID: 16552752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.